卡尔曼综合征
促性腺激素减退症
成纤维细胞生长因子受体1
生物
突变
内分泌学
医学
遗传学
内科学
基因
激素
疾病
成纤维细胞生长因子
受体
传染病(医学专业)
2019年冠状病毒病(COVID-19)
作者
Shanshan Wang,Wanyi Zhao,Hui-Xiao Wu,Meng Shu,Jiaxin Yuan,Fang Li,Chao Xu
出处
期刊:PubMed
[National Institutes of Health]
日期:2022-10-20
卷期号:44 (10): 937-949
标识
DOI:10.16288/j.yczz.22-196
摘要
Idiopathic hypogonadotropic hypogonadism (IHH) is a rare endocrine disease characterized by gonadal dysplasia. According to whether the sense of smell is affected, this disorder is classified into Kallmann syndrome (KS) and normosmic isolated hypogonadotropic hypogonadism (nIHH). In this study, we reported a case of nIHH patient and explored the pathogenic mechanism of FGFR1 in nIHH. A FGFR1 variant (c.2008G>A, p.E670K) and a CEP290 variant (c.964G>A, p.D322N) were detected by the whole exome sequencing in this nIHH patient. Bioinformatic analysis revealed that this FGFR1 variant (c.2008G>A) causes structural perturbations in TK2 domain demonstrating that this variant result in FGFR1 loss-of-function and abnormal signaling. The identification of an additional CEP290 variant (c.964G>A) indicated that CEP290 might play a potential role in developmental abnormalities and inhibition of GnRH neuron release. A protein interaction network analysis showed that CEP290 was predicted to interact with FGFR1. In summary, our study identified the potential pathogenic mechanism(s) of the novel FGFR1 variant and indicated that CEP290 might play a role in the GnRH neuron migration route. Our findings expand the mutation spectrum of FGFR1 and CEP290 and provide a reference for clinical diagnosis and treatment of IHH.
科研通智能强力驱动
Strongly Powered by AbleSci AI